The Misha knee system is designed to be implanted in an outpatient procedure, Moximed said Aug. 16. It is intended as an alternative to total knee replacement for patients with mild to moderate osteoarthritis.
The series C equity and debt financing round was led by Advent Life Sciences, Moximed said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
